WO2021049743A3 - 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름 - Google Patents

히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름 Download PDF

Info

Publication number
WO2021049743A3
WO2021049743A3 PCT/KR2020/009178 KR2020009178W WO2021049743A3 WO 2021049743 A3 WO2021049743 A3 WO 2021049743A3 KR 2020009178 W KR2020009178 W KR 2020009178W WO 2021049743 A3 WO2021049743 A3 WO 2021049743A3
Authority
WO
WIPO (PCT)
Prior art keywords
salt
hydrolyzable film
hyaluronic acid
polyphenol compound
hydrolyzable
Prior art date
Application number
PCT/KR2020/009178
Other languages
English (en)
French (fr)
Other versions
WO2021049743A2 (ko
Inventor
이재혁
박순현
김기석
Original Assignee
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국화학연구원 filed Critical 한국화학연구원
Publication of WO2021049743A2 publication Critical patent/WO2021049743A2/ko
Publication of WO2021049743A3 publication Critical patent/WO2021049743A3/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K13/00Use of mixtures of ingredients not covered by one single of the preceding main groups, each of these compounds being essential
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/13Phenols; Phenolates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/16Biodegradable polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/011Nanostructured additives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00Properties
    • C08L2201/06Biodegradable
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/16Applications used for films

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름에 관한 것으로, CNT(carbon nano tube), 그래핀 및 마그네틱 파티클 형태의 나노필름을 다양한 곳에 전사시키고, 수용액 또는 체내 수분에 의해 녹아 없어질 수 있는 효과가 있으며, 독성이 없어 생체적합적이므로 의료분야에서 유용하게 사용될 수 있고, 전자소자 및 기존 포토리소그래프 공정에서는 잔여물이 남지 않아 소자의 품질 및 성능을 저하시키지 않는 전사체로 유용하게 사용될 수 있다.
PCT/KR2020/009178 2019-09-09 2020-07-13 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름 WO2021049743A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190111716A KR102372213B1 (ko) 2019-09-09 2019-09-09 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름
KR10-2019-0111716 2019-09-09

Publications (2)

Publication Number Publication Date
WO2021049743A2 WO2021049743A2 (ko) 2021-03-18
WO2021049743A3 true WO2021049743A3 (ko) 2021-07-01

Family

ID=71783848

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/009178 WO2021049743A2 (ko) 2019-09-09 2020-07-13 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름

Country Status (5)

Country Link
US (1) US11834560B2 (ko)
EP (1) EP3789439A1 (ko)
JP (1) JP7050123B2 (ko)
KR (1) KR102372213B1 (ko)
WO (1) WO2021049743A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111337555A (zh) * 2020-03-24 2020-06-26 泉州师范学院 利用紫苏提取物制备还原氧化石墨烯-纳米金复合材料的方法及其在电化学传感器中的应用
CN114886844B (zh) * 2022-05-31 2023-05-23 安徽工程大学 一种基于酶促反应调控的壳聚糖/γ-聚谷氨酸/单宁酸水凝胶及其制备方法和应用
CN116281989B (zh) * 2023-04-12 2024-02-13 江西省科学院应用化学研究所 一种龙脑樟活性分子改性修饰石墨烯薄膜及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090040979A (ko) * 2007-10-23 2009-04-28 주식회사유한양행 히알루론산 또는 그의 염, 금속이온, 및 수-난용성생분해성 고분자를 포함하는 표적지향을 위한 나노입자 및그의 제조방법
KR20110035136A (ko) * 2009-09-29 2011-04-06 중앙대학교 산학협력단 초상자성 산화철 나노입자를 포함하는 색전제 및 그 제조 방법
JP2014214133A (ja) * 2013-04-26 2014-11-17 日立化成株式会社 ナノ薄膜転写シート製品の製造方法及びその転写方法
JP2015016614A (ja) * 2013-07-10 2015-01-29 日立化成株式会社 ナノ薄膜転写シート、ナノ薄膜転写シートの製造方法、及びナノ薄膜層の被着体への転写方法
KR20190103559A (ko) * 2018-02-27 2019-09-05 서울대학교산학협력단 생체안정성과 기계적 물성이 향상된 생분해성 고분자 하이드로겔 복합체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
DE102008008522A1 (de) * 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
KR101182033B1 (ko) 2009-07-08 2012-09-11 씨제이제일제당 (주) 외래종 유래의 글리세르알데하이드-3-포스페이트 디하이드로지나제의 활성을 획득한 코리네박테리움 속의 l-라이신 생산방법
US9889098B2 (en) * 2009-10-22 2018-02-13 Vizuri Health Sciences Llc Methods of making and using compositions comprising flavonoids
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
CA2815321C (en) 2010-10-22 2018-10-16 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US9069555B2 (en) 2011-03-21 2015-06-30 Intel Corporation Managing power consumption in a multi-core processor
KR20160094621A (ko) * 2015-02-02 2016-08-10 동우 화인켐 주식회사 수전사용 전도성 전사필름, 이를 이용한 코팅 방법
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
KR20180010361A (ko) * 2016-07-20 2018-01-31 중앙대학교 산학협력단 히알루론산 하이드로 겔 및 이의 제조 방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090040979A (ko) * 2007-10-23 2009-04-28 주식회사유한양행 히알루론산 또는 그의 염, 금속이온, 및 수-난용성생분해성 고분자를 포함하는 표적지향을 위한 나노입자 및그의 제조방법
KR20110035136A (ko) * 2009-09-29 2011-04-06 중앙대학교 산학협력단 초상자성 산화철 나노입자를 포함하는 색전제 및 그 제조 방법
JP2014214133A (ja) * 2013-04-26 2014-11-17 日立化成株式会社 ナノ薄膜転写シート製品の製造方法及びその転写方法
JP2015016614A (ja) * 2013-07-10 2015-01-29 日立化成株式会社 ナノ薄膜転写シート、ナノ薄膜転写シートの製造方法、及びナノ薄膜層の被着体への転写方法
KR20190103559A (ko) * 2018-02-27 2019-09-05 서울대학교산학협력단 생체안정성과 기계적 물성이 향상된 생분해성 고분자 하이드로겔 복합체 및 이의 제조방법

Also Published As

Publication number Publication date
US11834560B2 (en) 2023-12-05
US20210070951A1 (en) 2021-03-11
JP7050123B2 (ja) 2022-04-07
KR20210030557A (ko) 2021-03-18
JP2021042194A (ja) 2021-03-18
WO2021049743A2 (ko) 2021-03-18
EP3789439A1 (en) 2021-03-10
KR102372213B1 (ko) 2022-03-08

Similar Documents

Publication Publication Date Title
WO2021049743A3 (ko) 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름
RS53492B1 (en) 5-AMINO-2,3-DIHYDROPHTALAZINE-1,4-DION CRYSTAL FORMS FOR SODIUM CHLORIDE, THEIR PHARMACEUTICAL APPLICATION AND THE PROCEDURE FOR THEIR PRODUCTION
PH12016501835A1 (en) 5-substituted indazole -3- carboxamides and preparation and use thereof
NZ731095A (en) Compositions and methods for treating cns disorders
CR20200640A (es) Substituted thiophenecarboxamides and analogues as antibacterials agents
MX2014004738A (es) Derivados de (4-fenilimidazol-2-il)etilamina utiles como moduladores de canal de sodio.
AR098110A1 (es) Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina
BR112015031457A2 (pt) processo para preparar um produto do ácido hialurônico reticulado
JP2016518458A5 (ko)
CN103241817A (zh) 一种组合型絮凝剂
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
CN105494442A (zh) 一种水产养殖杀菌剂
IN2012DN06678A (ko)
GB201015078D0 (en) Endotracheal tube for mechanical ventilation
MX2019013562A (es) Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.
WO2012134424A3 (en) Purification of barium ion source
CN103907600B (zh) 一种氧化石墨烯复合龙脑的抗菌材料
JP2014137599A5 (ko)
WO2016057660A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
MX2016014930A (es) Solucion de recubrimiento para conexion roscada para tubo o tuberia de conduccion y metodo de produccion de la conexion roscada para tubo o tuberia de conduccion.
ZA201801628B (en) Multi-metal catalyst composition for production of morphology controlled cnt's and process thereof
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
CN204521896U (zh) 一种新型的气管插管固定器
JP2014098037A5 (ko)
CN104370308A (zh) 一种水质高效净化剂

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20863921

Country of ref document: EP

Kind code of ref document: A2